Kus et al. [17] investigated 219 Turkish breast cancer patients and found that the CYP3A4 rs2740574 variant allele was associated with lower risk of neuropathy, especially for chemotherapy-induced peripheral neuropathies that interfered with activities of daily living. Here, CYP3A4 is linked to peripheral neuropathy.